Association between IL-32 genotypes and outcome in infection-associated acute lung injury

Por Arcaroli, John J, Liu, Nianjun, Yi, Nengjun, Abraham, Edward
Publicado em 2011

Similarity-based multi-marker association tests for continuous traits

Por Lin, Wan-Yu, Tiwari, Hemant K., Gao, Guimin, Zhang, Kui, Arcaroli, John J, Abraham, Edward, Liu, Nianjun
Publicado em 2012

Procedure for Horizontal Transfer of Patient-Derived Xenograft Tumors to Eliminate Corynebacterium bovis

Por Manuel, Christopher A, Bagby, Stacey M, Reisinger, Julie A, Pugazhenthi, Umarani, Pitts, Todd M, Keysar, Stephen B, Arcaroli, John J, Leszczynski, Jori K
Publicado no J Am Assoc Lab Anim Sci (2017)

Gene Array and Fluorescence In situ Hybridization Biomarkers of Activity of Saracatinib (AZD0530), a Src Inhibitor, in a Preclinical Model of Colorectal Cancer

Por Arcaroli, John J., Touban, Basel M., Tan, Aik Choon, Varella-Garcia, Marileila, Powell, Rebecca W., Eckhardt, S. Gail, Elvin, Paul, Gao, Dexiang, Messersmith, Wells A.
Publicado em 2010

Patient-derived tumour xenografts as models for oncology drug development

Por Tentler, John J., Tan, Aik Choon, Weekes, Colin D., Jimeno, Antonio, Leong, Stephen, Pitts, Todd M., Arcaroli, John J., Messersmith, Wells A., Eckhardt, S. Gail
Publicado em 2012

ALDH1B1 as a Modulator of Pancreatic Adenocarcinoma

Por Singh, Surendra, Arcaroli, John J., Orlicky, David J., Chen, Ying, Messersmith, Wells A., Bagby, Stacey, Purkey, Alicia, Quackenbush, Kevin S., Thompson, David C., Vasiliou, Vasilis
Publicado no Pancreas (2016)

An Improved High Yield Total Synthesis and Cytotoxicity Study of the Marine Alkaloid Neoamphimedine: An ATP-Competitive Inhibitor of Topoisomerase IIα and Potent Anticancer Agent

Por Li, Linfeng, Abraham, Adedoyin D., Zhou, Qiong, Ali, Hadi, O’Brien, Jeremy V., Hamill, Brayden D., Arcaroli, John J., Messersmith, Wells A., LaBarbera, Daniel V.
Publicado em 2014

Extracellular Superoxide Dismutase Haplotypes Are Associated with Acute Lung Injury and Mortality

Por Arcaroli, John J., Hokanson, John E., Abraham, Edward, Geraci, Mark, Murphy, James R., Bowler, Russell P., Dinarello, Charles A., Silveira, Lori, Sankoff, Jeff, Heyland, Daren, Wischmeyer, Paul, Crapo, James D.
Publicado em 2009

ALDH+ tumor‐initiating cells exhibiting gain in NOTCH1 gene copy number have enhanced regrowth sensitivity to a γ‐secretase inhibitor and irinotecan in colorectal cancer

Por Arcaroli, John J., Powell, Rebecca W., Varella-Garcia, Marileila, McManus, Martine, Tan, Aik Choon, Quackenbush, Kevin S., Pitts, Todd M., Gao, Dexiang, Spreafico, Anna, Dasari, Arvind, Touban, Basel M., Messersmith, Wells A.
Publicado em 2012

Evaluation of TAK-264, an Antibody-Drug Conjugate in Pancreatic Cancer Cell Lines and Patient-Derived Xenograft Models

Por Schreiber, Anna R., Nguyen, Anna, Bagby, Stacey M., Arcaroli, John J., Yacob, Betelehem W., Quackenbush, Kevin, Guy, Joe L., Crowell, Thomas, Stringer, Bradley, Danaee, Hadi, Kalebic, Thea, Messersmith, Wells A., Pitts, Todd M.
Publicado no Clin Cancer Drugs (2018)

Common PIK3CA Mutants and a Novel 3′ UTR Mutation Are Associated with Increased Sensitivity to Saracatinib

Por Arcaroli, John J., Quackenbush, Kevin S., Powell, Rebecca W., Pitts, Todd M., Spreafico, Anna, Varella-Garcia, Marileila, Bemis, Lynne, Tan, Aik Choon, Reinemann, Jaclyn M., Touban, Basel M., Dasari, Arvind, Eckhardt, S. Gail, Messersmith, Wells A.
Publicado em 2012

Lipid catabolism inhibition sensitizes prostate cancer cells to antiandrogen blockade

Por Flaig, Thomas W., Salzmann-Sullivan, Maren, Su, Lih-Jen, Zhang, Zhiyong, Joshi, Molishree, Gijón, Miguel A., Kim, Jihye, Arcaroli, John J., Van Bokhoven, Adrie, Lucia, M. Scott, La Rosa, Francisco G., Schlaepfer, Isabel R.
Publicado no Oncotarget (2017)

CDK1 interacts with Sox2 and promotes tumor initiation in human melanoma

Por Menon, Dinoop Ravindran, Luo, Yuchun, Arcaroli, John J., Liu, Sucai, KrishnanKutty, Lekha Nair, Osborne, Douglas G., Li, Yang, Samson, Jenny Mae, Bagby, Stacey, Tan, Aik-Choon, Robinson, William A., Messersmith, Wells A., Fujita, Mayumi
Publicado no Cancer Res (2018)

Preclinical Activity of the Rational Combination of Selumetinib (AZD6244) in Combination with Vorinostat in KRAS-Mutant Colorectal Cancer Models

Por Morelli, M. Pia, Tentler, John J., Kulikowski, Gillian N., Tan, Aik-Choon, Bradshaw-Pierce, Erica L., Pitts, Todd M., Brown, Amy M., Nallapareddy, Sujatha, Arcaroli, John J., Serkova, Natalie J., Hidalgo, Manuel, Ciardiello, Fortunato, Eckhardt, S. Gail
Publicado em 2011

Dual compartmental targeting of cell cycle and angiogenic kinases in colorectal cancer models

Por Capasso, Anna, Pitts, Todd M., Klauck, Peter J., Bagby, Stacey M., Westbrook, Lindsey, Kaplan, Jeffrey, Soleimani, Milad, Spreafico, Anna, Tentler, John J., Diamond, Jennifer R., Arcaroli, John J., Messersmith, Wells A., Eckhardt, Sue G., Leong, Stephen
Publicado no Anticancer Drugs (2018)

Antitumor activity of a potent MEK inhibitor, TAK-733, against colorectal cancer cell lines and patient derived xenografts

Por Lieu, Christopher H., Klauck, Peter J., Henthorn, Patrick K., Tentler, John J., Tan, Aik-Choon, Spreafico, Anna, Selby, Heather M., Britt, Blair C., Bagby, Stacey M., Arcaroli, John J., Messersmith, Wells A., Pitts, Todd M., Eckhardt, S. Gail
Publicado no Oncotarget (2015)

Dual Pharmacological Targeting of the MAP Kinase and PI3K/mTOR Pathway in Preclinical Models of Colorectal Cancer

Por Pitts, Todd M., Newton, Timothy P., Bradshaw-Pierce, Erica L., Addison, Rebecca, Arcaroli, John J., Klauck, Peter J., Bagby, Stacey M., Hyatt, Stephanie L., Purkey, Alicia, Tentler, John J., Tan, Aik Choon, Messersmith, Wells A., Eckhardt, S. Gail, Leong, Stephen
Publicado no PLoS One (2014)

The novel tankyrase inhibitor (AZ1366) enhances irinotecan activity in tumors that exhibit elevated tankyrase and irinotecan resistance

Por Quackenbush, Kevin S., Bagby, Stacey, Tai, Wai Meng, Messersmith, Wells A., Schreiber, Anna, Greene, Justin, Kim, Jihye, Wang, Guoliang, Purkey, Alicia, Pitts, Todd M., Nguyen, Anna, Gao, Dexiang, Blatchford, Patrick, Capasso, Anna, Schuller, Alwin G., Eckhardt, S. Gail, Arcaroli, John J.
Publicado no Oncotarget (2016)

The novel ATM inhibitor (AZ31) enhances antitumor activity in patient derived xenografts that are resistant to irinotecan monotherapy

Por Greene, Justin, Nguyen, Anna, Bagby, Stacey M., Jones, Gemma N., Tai, WM., Quackenbush, Kevin S., Schreiber, Anna, Messersmith, Wells A., Devaraj, Kalpana M., Blatchford, Patrick, Eckhardt, S. Gail, Cadogan, Elaine B., Hughes, Gareth D., Smith, Aaron, Pitts, Todd M., Arcaroli, John J.
Publicado no Oncotarget (2017)

Antitumor activity of the polo-like kinase inhibitor, TAK-960, against preclinical models of colorectal cancer

Por Klauck, Peter J., Bagby, Stacey M., Capasso, Anna, Bradshaw-Pierce, Erica L., Selby, Heather M., Spreafico, Anna, Tentler, John J., Tan, Aik Choon, Kim, Jihye, Arcaroli, John J., Purkey, Alicia, Messersmith, Wells A., Kuida, Keisuke, Gail Eckhardt, S., Pitts, Todd M.
Publicado no BMC Cancer (2018)